PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8+ tumor-infiltrating lymphocytes: highly sensitive detection using phosphor-integrated dot staining

被引：0
|
作者：
So Yamaki
Hiroaki Yanagimoto
Koji Tsuta
Hironori Ryota
Masanori Kon
机构：
[1] Kansai Medical University Hirakata Hospital,Department of Surgery
[2] Kansai Medical University,Department of Pathology and Laboratory Medicine
来源：
International Journal of Clinical Oncology | 2017年 / 22卷
关键词：
Pancreatic adenocarcinoma; PD-L1; Immunohistochemistry; Phosphor-integrated dots;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：726 / 733
页数：7
相关论文
共 50 条
  • [21] Heterogeneity of PD-L1 expression and CD8 tumor-infiltrating lymphocytes among subtypes of cutaneous adnexal carcinomas
    Lucie Duverger
    Amélie Osio
    Bernard Cribier
    Laurent Mortier
    Adèle De Masson
    Nicole Basset-Seguin
    Céleste Lebbé
    Maxime Battistella
    Cancer Immunology, Immunotherapy, 2019, 68 : 951 - 960
  • [22] Heterogeneity of PD-L1 expression and CD8 tumor-infiltrating lymphocytes among subtypes of cutaneous adnexal carcinomas
    Duverger, Lucie
    Osio, Amelie
    Cribier, Bernard
    Mortier, Laurent
    De Masson, Adele
    Basset-Seguin, Nicole
    Lebbe, Celeste
    Battistella, Maxime
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2019, 68 (06) : 951 - 960
  • [23] Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma
    Shimizu, Katsuhiko
    Okita, Riki
    Saisho, Shinsuke
    Maeda, Ai
    Nojima, Yuji
    Nakata, Masao
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 741 - 750
  • [24] PD-L1 expression in tumour-infiltrating lymphocytes is a poor prognostic factor for primary acral melanoma patients
    Ren, Min
    Dai, Bo
    Kong, Yun-Yi
    Lv, Jiao-Jie
    Cai, Xu
    HISTOPATHOLOGY, 2018, 73 (03) : 386 - 396
  • [25] PD-L1 expression and decreased tumor-infiltrating lymphocytes are associated with poor prognosis in patients with triple negative breast cancer
    Mori, H.
    Kubo, M.
    Yamaguti, R.
    Nishimura, R.
    Osako, T.
    Arima, N.
    Okumura, Y.
    Okido, M.
    Yamada, M.
    Kai, M.
    Kishimoto, J.
    Oda, Y.
    Nakamura, M.
    CANCER RESEARCH, 2017, 77
  • [26] Synergistic upregulation of PD-L1 in tumor cells and CD39 in tumor-infiltrating CD8+ T cells leads to poor prognosis in patients with hepatocellular carcinoma
    Kang, Xi
    Zhao, Sinan
    Lin, Shan
    Li, Jing
    Wang, Shunxiang
    ONCOLOGY LETTERS, 2024, 28 (02)
  • [27] High tumoral PD-L1 expression and low PD-1+ or CD8+ tumor-infiltrating lymphocytes are predictive of a poor prognosis in primary diffuse large B-cell lymphoma of the central nervous system
    Kim, Sehui
    Nam, Soo Jeong
    Park, Changhee
    Kwon, Dohee
    Yim, Jeemin
    Song, Seung Geun
    Ock, Chan-Young
    Kim, Young A.
    Park, Sung Hye
    Kim, Tae Min
    Jeon, Yoon Kyung
    ONCOIMMUNOLOGY, 2019, 8 (09):
  • [28] A High PD-L1 Expression in Non-Small Cell Lung Cancer Correlates with Expression of SPOP and CD8 Tumor-Infiltrating Lymphocytes
    Inoue, M.
    Yoshida, J.
    Oka, S.
    Honda, Y.
    Chikaishi, Y.
    Yasuda, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S461 - S461
  • [29] PD-L1 Expression in Tumour Infiltrating Lymphocytes, Not in Tumour Cells, Is a Poor Prognostic Factor for Primary Acral Melanoma Patients
    Ren, Min
    Dai, Bo
    Kong, Yunyi
    Lv, Jiaojie
    Cai, Xu
    MODERN PATHOLOGY, 2018, 31 : 206 - 208
  • [30] PD-L1 Expression in Tumour Infiltrating Lymphocytes, Not in Tumour Cells, Is a Poor Prognostic Factor for Primary Acral Melanoma Patients
    Ren, Min
    Dai, Bo
    Kong, Yunyi
    Lv, Jiaojie
    Cai, Xu
    LABORATORY INVESTIGATION, 2018, 98 : 206 - 208
12345